View on Pubmed.gov 36209124 | View on doi.org 10.1186/s12967-...
Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions.
- Department of Nutrition and Dietetics, Gazi University, Faculty of Health Sciences, 06490, Ankara, Emek, Turkey. duyguturkozu@gazi.edu.tr.
- Department of Nutrition and Dietetics, Burdur Mehmet Akif Ersoy University, İstiklal Yerleşkesi, 15030, Burdur, Turkey.
- Department of Nutrition and Dietetics, Gazi University, Faculty of Health Sciences, 06490, Ankara, Emek, Turkey.
- Department of Nutrition and Dietetics, Kırıkkale University, 71100, Kırıkkale, Merkez, Turkey.
- Department of Seafood Processing Technology, Faculty of Fisheries, Cukurova University, 01330, Balcali, Adana, Turkey.
- Department of Agricultural Sciences, University of Naples Federico II, 80055, Portici, NA, Italy. rafcapas@unina.it.
Abstract
Probiotics have been defined as "living microorganisms that create health benefits in the host when taken in sufficient amounts. Recent developments in the understanding of the relationship between the microbiom and its host have shown evidence about the promising potential of probiotics to improve certain health problems. However, today, there are some confusions about traditional and new generation foods containing probiotics, naming and classifications of them in scientific studies and also their marketing. To clarify this confusion, the Food and Drug Administration (FDA) declared that it has made a new category definition called "live biotherapeutic products" (LBPs). Accordingly, the FDA has designated LBPs as "a biological product that: i)contains live organisms, such as bacteria; ii)is applicable to the prevention, treatment, or cure of a disease/condition of human beings; and iii) is not a vaccine". The accumulated literature focused on LBPs to determine effective strains in health and disease, and often focused on obesity, diabetes, and certain diseases like inflammatory bowel disease (IBD).However, microbiome also play an important role in the pathogenesis of diseases that age day by day in the modern world via gut-brain axis. Herein, we discuss the novel roles of LBPs in some gut-brain axis related conditions in the light of recent studies. This article may be of interest to a broad readership including those interested in probiotics as LBPs, their health effects and safety, also gut-brain axis.
References
Sci Rep. 2017 Oct 19;7(1):13537
Neurosci Biobehav Rev. 2021 Sep;128:549-557
Neurobiol Stress. 2020 Mar 20;12:100216
Clin Nutr. 2019 Apr;38(2):522-528
Cited by 47 citations (total)
Journal Article Review
Gut Microbiota and Immunotherapy for Alzheimer's Disease.
Electronic publication date December 15, 2022
Chun-Ling Dai [...] Cheng-Xin Gong et al.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that eventually leads to dementia and death of the patient. Currently, no...
Journal Article
Multi-omics analyses of Bacillus amyloliquefaciens treated mice infected with Schistosoma japonicum reveal dynamics change of intestinal microbiome and its associations with host metabolism.
Electronic publication date October 28, 2024
Hao Chen [...] Zheng Yu et al.
BACKGROUND
Schistosomiasis japonica is a serious threat to human health. It causes damage to the intestine and liver. Probiotic therapy has...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
Substances
Copyright
© 2022. The Author(s).